XTalks

MAY 22, 2023

. “This unique product is a result of our vast experience in hyaluronic acid science and complements our current collection of hyaluronic acid products, with the Juvéderm collection of fillers and SkinMedica topicals.”

Filler 92

Filler FDA Approval Dermatology In-Vivo 92

XTalks

MAY 25, 2023

The team discussed the benefits and novelty of the product, as well as their personal opinions of hyaluronic acid products for skincare and the costs of such treatments.

Filler 52

Filler Life Science FDA Approval Drugs 52

pharmaphorum

MAY 10, 2021

The committee said there is “at least a reasonable possibility” that the vaccine can cause the side effect in people previously treated with dermal fillers, often used for cosmetic purposes.

Vaccine 122

Vaccine Vaccination Filler Cosmetics 122

XTalks

JULY 5, 2022

Common anti-aging procedures include Botox or dermal fillers, which can reduce the appearance of wrinkles, sagging and increase volume in the face where desired. It’s a treatment that fulfills a big unmet need in cosmetic procedures,” citing noteworthy results seen firsthand in patients.

Cosmetics 98

Cosmetics Clinical Trials Clinical Trials Botox 98

Roots Analysis

JANUARY 3, 2024

Medical aesthetics is a growing area of modern medicine that focuses on improving the cosmetic appearance of an individual through various medical treatments. However, Botulinum toxin was the real game-changer when it was approved for cosmetic use by the FDA in 2002.

Filler 40

Filler Cosmetics Production Dermatology 40

Trialfacts

JANUARY 23, 2024

radiotherapy) in the past 6 months Must not have performed any aesthetic treatment on the face within the past 12 months, including injections (fillers/ Botox/ permanent implants, etc.), We are experts in the testing of haircare, cosmetics, and other personal care products. We help prove products are safe and effective.

Research 52

Research Botox Filler Cosmetics 52

The Pharma Data

NOVEMBER 4, 2020

Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). For additional information, please visit www.crescitatherapeutics.com.

Licensing 40

Licensing Licensing Dermatology Production 40